{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:55:49Z","timestamp":1792205749875,"version":"4.4.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["EPCD000025"],"award-info":[{"award-number":["EPCD000025"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["MRF2024419"],"award-info":[{"award-number":["MRF2024419"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76837-1","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:54:14Z","timestamp":1787183654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug screen and machine learning predict neuroprotective agents in a preclinical human model of childhood dementia"],"prefix":"10.1038","volume":"17","author":[{"given":"Zarina","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0852-0723","authenticated-orcid":false,"given":"Ella","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9531-1180","authenticated-orcid":false,"given":"Alejandra","family":"Nore\u00f1a Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5517-5903","authenticated-orcid":false,"given":"Manam Inushi","family":"De Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5661-3787","authenticated-orcid":false,"given":"Cade","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6254-0385","authenticated-orcid":false,"given":"Robert","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenne","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5974-7901","authenticated-orcid":false,"given":"Paris","family":"Mazzachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4984-5963","authenticated-orcid":false,"given":"Sebastian","family":"Loskarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5029-2198","authenticated-orcid":false,"given":"Siti N.","family":"Mubarokah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5175-4839","authenticated-orcid":false,"given":"Leanne","family":"Winner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-6491","authenticated-orcid":false,"given":"Drew","family":"Neavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0870-0338","authenticated-orcid":false,"given":"Megan","family":"Maack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9763-344X","authenticated-orcid":false,"given":"Kristina L.","family":"Elvidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6314-359X","authenticated-orcid":false,"given":"Lisa","family":"Melton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2154-5950","authenticated-orcid":false,"given":"Mark R.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M.","family":"Hemsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2409-9239","authenticated-orcid":false,"given":"Nicholas","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8321-0852","authenticated-orcid":false,"given":"Cedric","family":"Bardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"76837_CR1","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddy186","volume":"27","author":"MS Elitt","year":"2018","unstructured":"Elitt, M. S., Barbar, L. & Tesar, P. J. Drug screening for human genetic diseases using iPSC models. Hum. Mol. Genet. 27, R89\u2013R98 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"76837_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/nyas.14012","volume":"1471","author":"MC Silva","year":"2020","unstructured":"Silva, M. C. & Haggarty, S. J. Human pluripotent stem cell-derived models and drug screening in CNS precision medicine. Ann. N. Y Acad. Sci. 1471, 18\u201356 (2020).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"76837_CR3","doi-asserted-by":"publisher","first-page":"7441","DOI":"10.1523\/JNEUROSCI.0636-16.2016","volume":"36","author":"E Aflaki","year":"2016","unstructured":"Aflaki, E. et al. A New Glucocerebrosidase Chaperone Reduces alpha-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism. J. Neurosci. 36, 7441\u20137452 (2016).","journal-title":"J. Neurosci."},{"key":"76837_CR4","doi-asserted-by":"publisher","unstructured":"Bonaventura, G. et al. iPSCs: A preclinical drug research tool for neurological disorders. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22094596 (2021).","DOI":"10.3390\/ijms22094596"},{"key":"76837_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00911-y","volume":"8","author":"W Guo","year":"2017","unstructured":"Guo, W. et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat. Commun. 8, 861 (2017).","journal-title":"Nat. Commun."},{"key":"76837_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.683459","volume":"9","author":"S Azam","year":"2021","unstructured":"Azam, S., Haque, M. E., Balakrishnan, R., Kim, I. S. & Choi, D. K. The ageing brain: molecular and cellular basis of neurodegeneration. Front. Cell Dev. Biol. 9, 683459 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"76837_CR7","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41593-018-0237-7","volume":"21","author":"L Gan","year":"2018","unstructured":"Gan, L., Cookson, M. R., Petrucelli, L. & La Spada, A. R. Converging pathways in neurodegeneration, from genetics to mechanisms. Nat. Neurosci. 21, 1300\u20131309 (2018).","journal-title":"Nat. Neurosci."},{"key":"76837_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrn1886","volume":"7","author":"MP Mattson","year":"2006","unstructured":"Mattson, M. P. & Magnus, T. Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 7, 278\u2013294 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"76837_CR9","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1523\/JNEUROSCI.0628-16.2016","volume":"36","author":"JR Mazzulli","year":"2016","unstructured":"Mazzulli, J. R. et al. Activation of beta-Glucocerebrosidase Reduces Pathological alpha-Synuclein and Restores Lysosomal Function in Parkinson\u2019s Patient Midbrain Neurons. J. Neurosci. 36, 7693\u20137706 (2016).","journal-title":"J. Neurosci."},{"key":"76837_CR10","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s43587-021-00150-3","volume":"1","author":"VN Gladyshev","year":"2021","unstructured":"Gladyshev, V. N. et al. Molecular damage in Aging. Nat. Aging 1, 1096\u20131106 (2021).","journal-title":"Nat. Aging"},{"key":"76837_CR11","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/brain\/awz360","volume":"143","author":"VA Pandya","year":"2019","unstructured":"Pandya, V. A. & Patani, R. Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective. Brain 143, 1057\u20131072 (2019).","journal-title":"Brain"},{"key":"76837_CR12","doi-asserted-by":"publisher","first-page":"E2725","DOI":"10.1073\/pnas.1504393112","volume":"112","author":"C Bardy","year":"2015","unstructured":"Bardy, C. et al. Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro. Proc. Natl. Acad. Sci. USA 112, E2725\u2013E2734 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76837_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.stemcr.2022.01.013","volume":"17","author":"B Milky","year":"2022","unstructured":"Milky, B. et al. Long-term adherence of human brain cells in vitro is enhanced by charged amine-based plasma polymer coatings. Stem Cell Rep. 17, 489\u2013506 (2022).","journal-title":"Stem Cell Rep."},{"key":"76837_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25344-6","volume":"12","author":"R Bassil","year":"2021","unstructured":"Bassil, R. et al. Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia. Nat. Commun. 12, 5220 (2021).","journal-title":"Nat. Commun."},{"key":"76837_CR15","doi-asserted-by":"publisher","unstructured":"Viana, G. M. et al. Brain pathology in mucopolysaccharidoses (MPS) patients with neurological forms. J. Clin. Med. 9, https:\/\/doi.org\/10.3390\/jcm9020396 (2020).","DOI":"10.3390\/jcm9020396"},{"key":"76837_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.968297","volume":"13","author":"DA do Valle","year":"2022","unstructured":"do Valle, D. A., Santos, M., Telles, B. A. & Cordeiro, M. L. Neurological, neurobehavioral, and radiological alterations in patients with mucopolysaccharidosis III (Sanfilippo\u2019s syndrome) in Brazil. Front. Neurol. 13, 968297 (2022).","journal-title":"Front. Neurol."},{"key":"76837_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00401-007-0325-3","volume":"115","author":"K Hamano","year":"2008","unstructured":"Hamano, K., Hayashi, M., Shioda, K., Fukatsu, R. & Mizutani, S. Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue. Acta Neuropathol. 115, 547\u2013559 (2008).","journal-title":"Acta Neuropathol."},{"key":"76837_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.brainres.2009.03.071","volume":"1279","author":"GR Villani","year":"2009","unstructured":"Villani, G. R. et al. Mucopolysaccharidosis IIIB: oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis. Brain Res. 1279, 99\u2013108 (2009).","journal-title":"Brain Res."},{"key":"76837_CR19","doi-asserted-by":"crossref","unstructured":"Barthelson, K., Protzman, R. A., Snel, M. F., Hemsley, K. & Lardelli, M. Multi-omics analyses of early-onset familial Alzheimer's disease and Sanfilippo syndrome zebrafish models reveal commonalities in disease mechanisms. Biochim. Biophys. Acta. Mol. Basis Dis. 1871, 167651 (2025).","DOI":"10.1016\/j.bbadis.2024.167651"},{"key":"76837_CR20","doi-asserted-by":"publisher","unstructured":"Heon-Roberts, R., Nguyen, A. L. A. & Pshezhetsky, A. V. Molecular bases of neurodegeneration and cognitive decline, the major burden of sanfilippo disease. J. Clin. Med. 9, https:\/\/doi.org\/10.3390\/jcm9020344 (2020).","DOI":"10.3390\/jcm9020344"},{"key":"76837_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/jmg.11.2.123","volume":"11","author":"PS Harper","year":"1974","unstructured":"Harper, P. S. et al. Sanfilippo A disease in the fetus. J. Med. Genet. 11, 123\u2013132 (1974).","journal-title":"J. Med. Genet."},{"key":"76837_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10545-013-9661-8","volume":"37","author":"D Buhrman","year":"2014","unstructured":"Buhrman, D., Thakkar, K., Poe, M. & Escolar, M. L. Natural history of Sanfilippo syndrome type A. J. Inherit. Metab. Dis. 37, 431\u2013437 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"76837_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06692-9","volume":"15","author":"TY Chen","year":"2024","unstructured":"Chen, T. Y. et al. Mature neurons from iPSCs unveil neurodegeneration-related pathways in mucopolysaccharidosis type II: GSK-3beta inhibition for therapeutic potential. Cell Death Dis. 15, 302 (2024).","journal-title":"Cell Death Dis."},{"key":"76837_CR24","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1515\/jpem-2020-0742","volume":"34","author":"W Kong","year":"2021","unstructured":"Kong, W. et al. Global epidemiology of mucopolysaccharidosis type III (Sanfilippo syndrome): an updated systematic review and meta-analysis. J. Pediatr. Endocrinol. Metab. 34, 1225\u20131235 (2021).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"76837_CR25","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2741\/4463","volume":"21","author":"J Jakobkiewicz-Banecka","year":"2016","unstructured":"Jakobkiewicz-Banecka, J. et al. Glycosaminoglycans and mucopolysaccharidosis type III. Front Biosci. 21, 1393\u20131409 (2016).","journal-title":"Front Biosci."},{"key":"76837_CR26","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/j.ymgme.2019.11.129","volume":"129","author":"K Flanigan","year":"2020","unstructured":"Flanigan, K. et al. Interim results of Transpher A, a multicenter, single-dose, phase 1\/2 clinical trial of ABO-102 gene therapy for Sanfilippo syndrome type A (mucopolysaccharidosis type IIIA). Mol. Genet. Metab. 129, S56\u2013S57 (2020).","journal-title":"Mol. Genet. Metab."},{"key":"76837_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/BF01713010","volume":"66","author":"AC Sewell","year":"1988","unstructured":"Sewell, A. C. Urinary screening for disorders of heteroglycan metabolism. Results of 10 years experience with a comprehensive system. Klin. Wochenschr. 66, 48\u201353 (1988).","journal-title":"Klin. Wochenschr."},{"key":"76837_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ajmg.a.33779","volume":"155A","author":"B Heron","year":"2011","unstructured":"Heron, B. et al. Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am. J. Med. Genet. A 155A, 58\u201368 (2011).","journal-title":"Am. J. Med. Genet. A"},{"key":"76837_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0796-4","volume":"13","author":"T Zelei","year":"2018","unstructured":"Zelei, T., Csetneki, K., Voko, Z. & Siffel, C. Epidemiology of Sanfilippo syndrome: results of a systematic literature review. Orphanet J. Rare Dis. 13, 53 (2018).","journal-title":"Orphanet J. Rare Dis."},{"key":"76837_CR30","volume":"19","author":"SJ Chin","year":"2022","unstructured":"Chin, S. J. & Fuller, M. Prevalence of lysosomal storage disorders in Australia from 2009 to 2020. Lancet Reg. Health West Pac. 19, 100344 (2022).","journal-title":"Lancet Reg. Health West Pac."},{"key":"76837_CR31","doi-asserted-by":"publisher","unstructured":"Mazzachi, P. et al. Modelling synaptic dysfunction in childhood dementia using human iPSC-derived cortical networks. Nat. Commun. 17, 3161 https:\/\/doi.org\/10.1038\/s41467-026-71112-9 (2026).","DOI":"10.1038\/s41467-026-71112-9"},{"key":"76837_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41592-024-02555-5","volume":"22","author":"N Caporale","year":"2025","unstructured":"Caporale, N. et al. Multiplexing cortical brain organoids for the longitudinal dissection of developmental traits at single-cell resolution. Nat. Methods 22, 358\u2013370 (2025).","journal-title":"Nat. Methods"},{"key":"76837_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38704-1","volume":"14","author":"DR Neavin","year":"2023","unstructured":"Neavin, D. R. et al. A village in a dish model system for population-scale hiPSC studies. Nat. Commun. 14, 3240 (2023).","journal-title":"Nat. Commun."},{"key":"76837_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10545-012-9535-5","volume":"36","author":"J de Ruijter","year":"2013","unstructured":"de Ruijter, J. et al. Heparan sulfate derived disaccharides in plasma and total urinary excretion of glycosaminoglycans correlate with disease severity in Sanfilippo disease. J. Inherit. Metab. Dis. 36, 271\u2013279 (2013).","journal-title":"J. Inherit. Metab. Dis."},{"key":"76837_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4155\/bio.15.243","volume":"8","author":"H Naimy","year":"2016","unstructured":"Naimy, H. et al. A novel LC-MS\/MS assay for heparan sulfate screening in the cerebrospinal fluid of mucopolysaccharidosis IIIA patients. Bioanalysis 8, 285\u2013295 (2016).","journal-title":"Bioanalysis"},{"key":"76837_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ymgme.2016.12.010","volume":"120","author":"F Kubaski","year":"2017","unstructured":"Kubaski, F. et al. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses. Mol. Genet. Metab. 120, 247\u2013254 (2017).","journal-title":"Mol. Genet. Metab."},{"key":"76837_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/03008207509152193","volume":"4","author":"HK Kleinman","year":"1975","unstructured":"Kleinman, H. K., Silbert, J. E. & Silbert, C. K. Heparan sulfate of skin fibroblasts grown in culture. Connect Tissue Res. 4, 17\u201323 (1975).","journal-title":"Connect Tissue Res."},{"key":"76837_CR38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ymgme.2004.05.005","volume":"82","author":"PS Savas","year":"2004","unstructured":"Savas, P. S., Hemsley, K. M. & Hopwood, J. J. Intracerebral injection of sulfamidase delays neuropathology in murine MPS-IIIA. Mol. Genet. Metab. 82, 273\u2013285 (2004).","journal-title":"Mol. Genet. Metab."},{"key":"76837_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1203\/01.PDR.0000129661.40499.12","volume":"56","author":"BL Gliddon","year":"2004","unstructured":"Gliddon, B. L. & Hopwood, J. J. Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice. Pediatr. Res. 56, 65\u201372 (2004).","journal-title":"Pediatr. Res."},{"key":"76837_CR40","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/glycob\/9.12.1389","volume":"9","author":"M Bhaumik","year":"1999","unstructured":"Bhaumik, M. et al. A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome). Glycobiology 9, 1389\u20131396 (1999).","journal-title":"Glycobiology"},{"key":"76837_CR41","first-page":"462","volume":"82","author":"BJ Wallace","year":"1966","unstructured":"Wallace, B. J., Kaplan, D., Adachi, M., Schneck, L. & Volk, B. W. Mucopolysaccharidosis type 3. Morphologic and biochemical studies of two siblings with Sanfilippo syndrome. Arch. Pathol. 82, 462\u2013473 (1966).","journal-title":"Arch. Pathol."},{"key":"76837_CR42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.nrl.2011.10.007","volume":"27","author":"ML Calleja Gero","year":"2012","unstructured":"Calleja Gero, M. L. et al. Neuroimaging findings in patient series with mucopolysaccharidosis. Neurologia 27, 407\u2013413 (2012).","journal-title":"Neurologia"},{"key":"76837_CR43","doi-asserted-by":"publisher","first-page":"e35787","DOI":"10.1371\/journal.pone.0035787","volume":"7","author":"FL Wilkinson","year":"2012","unstructured":"Wilkinson, F. L. et al. Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB. PLoS ONE 7, e35787 (2012).","journal-title":"PLoS ONE"},{"key":"76837_CR44","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","volume":"41","author":"F Giovannoni","year":"2020","unstructured":"Giovannoni, F. & Quintana, F. J. The Role of Astrocytes in CNS Inflammation. Trends Immunol. 41, 805\u2013819 (2020).","journal-title":"Trends Immunol."},{"key":"76837_CR45","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.4103\/1673-5374.306064","volume":"16","author":"ZB Ding","year":"2021","unstructured":"Ding, Z. B. et al. Astrocytes: a double-edged sword in neurodegenerative diseases. Neural Regen. Res. 16, 1702\u20131710 (2021).","journal-title":"Neural Regen. Res."},{"key":"76837_CR46","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.expneurol.2004.08.008","volume":"190","author":"D Wong","year":"2004","unstructured":"Wong, D., Dorovini-Zis, K. & Vincent, S. R. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp. Neurol. 190, 446\u2013455 (2004).","journal-title":"Exp. Neurol."},{"key":"76837_CR47","doi-asserted-by":"publisher","unstructured":"Walker, C. D., Risher, W. C. & Risher, M. L. Regulation of synaptic development by astrocyte signaling factors and their emerging roles in substance abuse. Cells 9, https:\/\/doi.org\/10.3390\/cells9020297 (2020).","DOI":"10.3390\/cells9020297"},{"key":"76837_CR48","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","volume":"46","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. & Barres, B. A. Reactive astrocytes: production, function, and therapeutic potential. Immunity 46, 957\u2013967 (2017).","journal-title":"Immunity"},{"key":"76837_CR49","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"76837_CR50","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1038\/sj.emboj.7601378","volume":"25","author":"P Pelegrin","year":"2006","unstructured":"Pelegrin, P. & Surprenant, A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J. 25, 5071\u20135082 (2006).","journal-title":"EMBO J."},{"key":"76837_CR51","doi-asserted-by":"publisher","first-page":"C761","DOI":"10.1152\/ajpcell.00227.2008","volume":"295","author":"W Silverman","year":"2008","unstructured":"Silverman, W., Locovei, S. & Dahl, G. Probenecid, a gout remedy, inhibits pannexin 1 channels. Am. J. Physiol. Cell Physiol. 295, C761\u2013C767 (2008).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"76837_CR52","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aap8809","volume":"358","author":"TJ Nowakowski","year":"2017","unstructured":"Nowakowski, T. J. et al. Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortex. Science 358, 1318\u20131323 (2017).","journal-title":"Science"},{"key":"76837_CR53","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1016\/j.cell.2022.09.039","volume":"185","author":"CA Herring","year":"2022","unstructured":"Herring, C. A. et al. Human prefrontal cortex gene regulatory dynamics from gestation to adulthood at single-cell resolution. Cell 185, 4428\u20134447 (2022).","journal-title":"Cell"},{"key":"76837_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-023-01728-6","volume":"21","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. Single-cell Mayo Map (scMayoMap): an easy-to-use tool for cell type annotation in single-cell RNA-sequencing data analysis. BMC Biol. 21, 223 (2023).","journal-title":"BMC Biol."},{"key":"76837_CR55","doi-asserted-by":"publisher","unstructured":"Herbet, M. et al. Alteration in the expression of genes involved in cerebral glucose metabolism as a process of adaptation to stressful conditions. Brain Sci. 12, https:\/\/doi.org\/10.3390\/brainsci12040498 (2022).","DOI":"10.3390\/brainsci12040498"},{"key":"76837_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111001","volume":"39","author":"KL Krus","year":"2022","unstructured":"Krus, K. L. et al. Loss of Stathmin-2, a hallmark of TDP-43-associated ALS, causes motor neuropathy. Cell Rep. 39, 111001 (2022).","journal-title":"Cell Rep."},{"key":"76837_CR57","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-023-01533-1","volume":"8","author":"S Menge","year":"2023","unstructured":"Menge, S., Decker, L. & Freischmidt, A. Restoring expression of Stathmin-2: a novel strategy to treat TDP-43 proteinopathies. Signal Transduct. Target Ther. 8, 266 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"76837_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105051","volume":"145","author":"A Ratti","year":"2020","unstructured":"Ratti, A. et al. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons. Neurobiol. Dis. 145, 105051 (2020).","journal-title":"Neurobiol. Dis."},{"key":"76837_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.719247","volume":"9","author":"S Zhou","year":"2021","unstructured":"Zhou, S. et al. Long Non-coding RNAs in Pathogenesis of Neurodegenerative Diseases. Front. Cell Dev. Biol. 9, 719247 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"76837_CR60","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/jnc.14576","volume":"148","author":"M Hetman","year":"2019","unstructured":"Hetman, M. & Slomnicki, L. P. Ribosomal biogenesis as an emerging target of neurodevelopmental pathologies. J. Neurochem. 148, 325\u2013347 (2019).","journal-title":"J. Neurochem."},{"key":"76837_CR61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/adc.73.1.77","volume":"73","author":"MC Bax","year":"1995","unstructured":"Bax, M. C. & Colville, G. A. Behaviour in mucopolysaccharide disorders. Arch. Dis. Child 73, 77\u201381 (1995).","journal-title":"Arch. Dis. Child"},{"key":"76837_CR62","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10545-012-9572-0","volume":"36","author":"EM Cross","year":"2013","unstructured":"Cross, E. M. & Hare, D. J. Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders. J. Inherit. Metab. Dis. 36, 189\u2013200 (2013).","journal-title":"J. Inherit. Metab. Dis."},{"key":"76837_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-43","volume":"6","author":"MJ Valstar","year":"2011","unstructured":"Valstar, M. J., Marchal, J. P., Grootenhuis, M., Colland, V. & Wijburg, F. A. Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome). Orphanet J. Rare Dis. 6, 43 (2011).","journal-title":"Orphanet J. Rare Dis."},{"key":"76837_CR64","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/1566524015666150303003028","volume":"15","author":"R Gao","year":"2015","unstructured":"Gao, R. & Penzes, P. Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. Curr. Mol. Med. 15, 146\u2013167 (2015).","journal-title":"Curr. Mol. Med."},{"key":"76837_CR65","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.neuron.2015.07.033","volume":"87","author":"SB Nelson","year":"2015","unstructured":"Nelson, S. B. & Valakh, V. Excitatory\/inhibitory balance and circuit homeostasis in Autism Spectrum Disorders. Neuron 87, 684\u2013698 (2015).","journal-title":"Neuron"},{"key":"76837_CR66","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00401-022-02526-0","volume":"145","author":"P Scaduto","year":"2023","unstructured":"Scaduto, P. et al. Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer\u2019s disease neuropathologic change. Acta Neuropathol. 145, 303\u2013324 (2023).","journal-title":"Acta Neuropathol."},{"key":"76837_CR67","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/mp.2016.158","volume":"21","author":"C Bardy","year":"2016","unstructured":"Bardy, C. et al. Predicting the functional states of human iPSC-derived neurons with single-cell RNA-seq and electrophysiology. Mol. Psychiatry 21, 1573\u20131588 (2016).","journal-title":"Mol. Psychiatry"},{"key":"76837_CR68","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41586-024-07578-8","volume":"631","author":"N Anton-Bolanos","year":"2024","unstructured":"Anton-Bolanos, N. et al. Brain Chimeroids reveal individual susceptibility to neurotoxic triggers. Nature 631, 142\u2013149 (2024).","journal-title":"Nature"},{"key":"76837_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14457-z","volume":"11","author":"ASE Cuomo","year":"2020","unstructured":"Cuomo, A. S. E. et al. Single-cell RNA-sequencing of differentiating iPS cells reveals dynamic genetic effects on gene expression. Nat. Commun. 11, 810 (2020).","journal-title":"Nat. Commun."},{"key":"76837_CR70","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41588-021-00801-6","volume":"53","author":"J Jerber","year":"2021","unstructured":"Jerber, J. et al. Population-scale single-cell RNA-seq profiling across dopaminergic neuron differentiation. Nat. Genet. 53, 304\u2013312 (2021).","journal-title":"Nat. Genet."},{"key":"76837_CR71","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.stem.2023.01.010","volume":"30","author":"MF Wells","year":"2023","unstructured":"Wells, M. F. et al. Natural variation in gene expression and viral susceptibility revealed by neural progenitor cell villages. Cell Stem Cell 30, 312\u2013332 (2023).","journal-title":"Cell Stem Cell"},{"key":"76837_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112785","volume":"407","author":"W Huang","year":"2021","unstructured":"Huang, W. et al. Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells. Exp. Cell Res. 407, 112785 (2021).","journal-title":"Exp. Cell Res."},{"key":"76837_CR73","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jmb.2014.09.012","volume":"427","author":"J Bruyere","year":"2015","unstructured":"Bruyere, J. et al. Heparan sulfate saccharides modify focal adhesions: implication in mucopolysaccharidosis neuropathophysiology. J. Mol. Biol. 427, 775\u2013791 (2015).","journal-title":"J. Mol. Biol."},{"key":"76837_CR74","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1093\/hmg\/ddr285","volume":"20","author":"T Lemonnier","year":"2011","unstructured":"Lemonnier, T. et al. Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells. Hum. Mol. Genet. 20, 3653\u20133666 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"76837_CR75","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.stemcr.2015.08.016","volume":"5","author":"I Canals","year":"2015","unstructured":"Canals, I. et al. Activity and high-order effective connectivity alterations in Sanfilippo C patient-specific neuronal networks. Stem Cell Rep. 5, 546\u2013557 (2015).","journal-title":"Stem Cell Rep."},{"key":"76837_CR76","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymgme.2011.01.015","volume":"103","author":"A Arfi","year":"2011","unstructured":"Arfi, A. et al. Neuroinflammatory and oxidative stress phenomena in MPS IIIA mouse model: the positive effect of long-term aspirin treatment. Mol. Genet. Metab. 103, 18\u201325 (2011).","journal-title":"Mol. Genet. Metab."},{"key":"76837_CR77","doi-asserted-by":"publisher","unstructured":"Polgreen, L. E. et al. Anakinra in Sanfilippo syndrome: a phase 1\/2 trial. Nat. Med. 9, 2473\u20132479 https:\/\/doi.org\/10.1038\/s41591-024-03079-3 (2024).","DOI":"10.1038\/s41591-024-03079-3"},{"key":"76837_CR78","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/00004647-200110000-00001","volume":"21","author":"D Attwell","year":"2001","unstructured":"Attwell, D. & Laughlin, S. B. An energy budget for signaling in the grey matter of the brain. J. Cereb. Blood Flow. Metab. 21, 1133\u20131145 (2001).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"76837_CR79","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M Belanger","year":"2011","unstructured":"Belanger, M., Allaman, I. & Magistretti, P. J. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 14, 724\u2013738 (2011).","journal-title":"Cell Metab."},{"key":"76837_CR80","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1212\/WNL.0000000000002041","volume":"85","author":"T Bremova","year":"2015","unstructured":"Bremova, T. et al. Acetyl-dl-leucine in Niemann-Pick type C: A case series. Neurology 85, 1368\u20131375 (2015).","journal-title":"Neurology"},{"key":"76837_CR81","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa148","volume":"3","author":"E Kaya","year":"2021","unstructured":"Kaya, E. et al. Acetyl-leucine slows disease progression in lysosomal storage disorders. Brain Commun. 3, fcaa148 (2021).","journal-title":"Brain Commun."},{"key":"76837_CR82","doi-asserted-by":"publisher","first-page":"e0229585","DOI":"10.1371\/journal.pone.0229585","volume":"15","author":"GC Churchill","year":"2020","unstructured":"Churchill, G. C., Strupp, M., Galione, A. & Platt, F. M. Unexpected differences in the pharmacokinetics of N-acetyl-DL-leucine enantiomers after oral dosing and their clinical relevance. PLoS ONE 15, e0229585 (2020).","journal-title":"PLoS ONE"},{"key":"76837_CR83","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s41687-022-00447-w","volume":"6","author":"KA Porter","year":"2022","unstructured":"Porter, K. A. et al. Caregivers\u2019 assessment of meaningful and relevant clinical outcome assessments for Sanfilippo syndrome. J. Patient Rep. Outcomes 6, 40 (2022).","journal-title":"J. Patient Rep. Outcomes"},{"key":"76837_CR84","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40120-020-00226-z","volume":"10","author":"KA Porter","year":"2021","unstructured":"Porter, K. A. et al. Parent experiences of Sanfilippo syndrome impact and unmet treatment needs: a qualitative assessment. Neurol. Ther. 10, 197\u2013212 (2021).","journal-title":"Neurol. Ther."},{"key":"76837_CR85","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/ana.22092","volume":"68","author":"MJ Valstar","year":"2010","unstructured":"Valstar, M. J. et al. Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations. Ann. Neurol. 68, 876\u2013887 (2010).","journal-title":"Ann. Neurol."},{"key":"76837_CR86","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.stemcr.2017.06.018","volume":"9","author":"J Tcw","year":"2017","unstructured":"Tcw, J. et al. An efficient platform for astrocyte differentiation from human induced pluripotent stem cells. Stem Cell Rep. 9, 600\u2013614 (2017).","journal-title":"Stem Cell Rep."},{"key":"76837_CR87","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101\u20131108 (2008).","journal-title":"Nat. Protoc."},{"key":"76837_CR88","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1021\/acschemneuro.9b00328","volume":"10","author":"QQ He","year":"2019","unstructured":"He, Q. Q. et al. Synthetic disaccharide standards enable quantitative analysis of stored heparan sulfate in MPS IIIA murine brain regions. ACS Chem. Neurosci. 10, 3847\u20133858 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"76837_CR89","doi-asserted-by":"publisher","unstructured":"Zabolocki, M., Kolopelnyk, G. & Bardy, C. Patch-clamp recordings from human induced pluripotent stem cell-derived neurons. In The Handbook of Electrophysiology. 445\u2013475 https:\/\/doi.org\/10.1142\/9789819813766_0018 (2026).","DOI":"10.1142\/9789819813766_0018"},{"key":"76837_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03224-8","volume":"25","author":"D Neavin","year":"2024","unstructured":"Neavin, D. et al. Demuxafy: improvement in droplet assignment by integrating multiple single-cell demultiplexing and doublet detection methods. Genome Biol. 25, 94 (2024).","journal-title":"Genome Biol."},{"key":"76837_CR91","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/bioinformatics\/btz698","volume":"36","author":"AS Bais","year":"2020","unstructured":"Bais, A. S. & Kostka, D. scds: computational annotation of doublets in single-cell RNA sequencing data. Bioinformatics 36, 1150\u20131158 (2020).","journal-title":"Bioinformatics"},{"key":"76837_CR92","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cels.2020.05.010","volume":"11","author":"NJ Bernstein","year":"2020","unstructured":"Bernstein, N. J. et al. Solo: doublet identification in single-cell RNA-seq via semi-supervised deep learning. Cell Syst. 11, 95\u2013101 (2020).","journal-title":"Cell Syst."},{"key":"76837_CR93","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.1","volume":"10","author":"PL Germain","year":"2021","unstructured":"Germain, P. L., Lun, A., Garcia Meixide, C., Macnair, W. & Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Res. 10, 979 (2021).","journal-title":"F1000Res."},{"key":"76837_CR94","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41592-020-0820-1","volume":"17","author":"H Heaton","year":"2020","unstructured":"Heaton, H. et al. Souporcell: robust clustering of single-cell RNA-seq data by genotype without reference genotypes. Nat. Methods 17, 615\u2013620 (2020).","journal-title":"Nat. Methods"},{"key":"76837_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1865-2","volume":"20","author":"Y Huang","year":"2019","unstructured":"Huang, Y., McCarthy, D. J. & Stegle, O. Vireo: Bayesian demultiplexing of pooled single-cell RNA-seq data without genotype reference. Genome Biol. 20, 273 (2019).","journal-title":"Genome Biol."},{"key":"76837_CR96","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s43018-020-00154-9","volume":"2","author":"LM Richards","year":"2021","unstructured":"Richards, L. M. et al. Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity. Nat. Cancer 2, 157\u2013173 (2021).","journal-title":"Nat. Cancer"},{"key":"76837_CR97","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature20123","volume":"539","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature 539, 309\u2013313 (2016).","journal-title":"Nature"},{"key":"76837_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 14, 128 (2013).","journal-title":"BMC Bioinform."},{"key":"76837_CR99","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"76837_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with enrichr. Curr. Protoc. 1, e90 (2021).","journal-title":"Curr. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76837-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76837-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76837-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:02:20Z","timestamp":1789988540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76837-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76837"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76837-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.M. is the founder and Executive Director of the Sanfilippo Children\u2019s Foundation and is the founder, Director and CEO of the Childhood Dementia Initiative. N.S. and K.M.H. serve on the advisory boards of the Sanfilippo Children\u2019s Foundation and the Childhood Dementia Initiative. K.M.H. was also the Chair of the US National MPS Society Scientific Advisory Board. K.E. is Head of Scientific Affairs of the Childhood Dementia Initiative. L.M. was Head of Research at the Sanfilippo Children\u2019s Foundation. C.B. is an inventor on the BrainPhys patent (US Patent App. 18\/133,237). The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9980"}}